CROS NT Group launches Arithmos s.r.l. to keeping up with the new Innovation’s Challenges
Inheriting CROS NT’s 15 years experience and developing a strong sensibility for innovation investments, today Arithmos is a valuable partner to optimize companies performances and accelerate their growth into the market in an accurate, safe and cost-effective manner.
Arithmos, that before becoming a dedicated company was the CROS NT’s IT department, boasts many years collaborating with pharmaceutical, biotechnology and medical device industries providing a customized range of hosting solutions and superior quality training and e-learning services to enhance clinical trials success and face time-to-market pressures.
The company has developed, implemented and managed pharma applications to optimize product value across all phases of clinical processes. However, the proven expertise in Oracle Life Science Applications is a solid benchmark that companies can rely on to face their challenges.
Data is managed through Oracle Clinical and Oracle Clinical Remote Data Capture, while Oracle TMS and ARGUS address coding and adverse events management.
Focused on improving productivity and performance while decreasing costs, Arithmos counts on integration. The integration of systems into Oracle Life Sciences Applications environment allows clients managing their clinical trial information more efficiently, especially through the support of specific solutions such as: Clinical Trial Management Systems (CTMS), Interactive Voice Response Systems (IVRS), e-PRO, SAS®, Laboratory data and Safety data.
Arithmos understands that one of the keys to assure tangible results with the highest level of quality consists of the customization of services. Therefore, the company is dedicated to creating ad hoc software solutions which can be provided according to clients specific requirements by using cutting-edge approaches.
All Arithmos services are fully validated driving clinical programs to the optimization of productivity and the reduction of regulatory exposure.
To learn more about Arithmos, please visit www.arithmos.it and contact us by email firstname.lastname@example.org or call the headquarter at +39 045 585492.
CROS NT is a contract research organisation (CRO) providing outsourced services for Clinical Data Management, Statistics, Pharmacovigilance, Medical Writing and Hosting for Pharma-Life Sciences Solutions across all phases of drug development.
CROS NT srl
Via Germania, 2
Mail Us: email@example.com
Tel: +39 045 8202666
Fax: +39 045 8205875
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release CROS NT Group launches Arithmos s.r.l. to keeping up with the new Innovation’s Challenges here
News-ID: 141667 • Views: 1073
More Releases from CROS NT
CROS NT WINS A "BEST PRESENTATION" AT PhUSE 2010
Verona, Italy (26 NOVEMBER 2010) – Stefano Vezzoli, part of CROS NT’s highly qualified and experienced biostatistics team, won Best Presentation in the area of Statistics and Pharmacokinetics at the Pharmaceutical Users Software Exchange (PhUSE) conference in Berlin, Germany. Vezzoli’s presentation was titled “Inference for the Location Shift in 3x3 Crossover Studies: the Median-Scaling Method”. Vezzoli’s Paper Abstract In the case of non-normal study outcomes, a nonparametric approach may be used
CROS NT GROUP TO ATTEND THIRD ANNUAL ONCOLOGY CLINICAL TRIALS
Verona, Italy (23 NOVEMBER 2010) – The German subsidiary of the CROS NT Group, CROS DE GmbH, will be present at the Third Annual Oncology Clinical Trials in Munich, Germany from 29 November through 1 December. The therapeutic area of oncology is one of CROS NT’s areas of excellence regarding clinical trial experience, and the CROS DE management team is at the forefront of clinical trial consultancy in this field.
CROS NT appoints new Vice President for Germany
CROS NT (CRO) announces the appointment of Frank Freischläger as Vice President (VP) for CROS DE GmbH, the German affiliate of CROS NT. As a VP at CROS DE he will be responsible for all aspects, which is focused on successful clinical trial activities. CROS is very excited to adding Mr. Freischläger's depth of industry expertise to the CROS team. "Bringing someone of Frank's knowledge to an already strong team
CROS NT Announces its Expansion into German Market Creating CROS DE GmbH
CROS NT is pleased to announce its expansion into Europe through the creation of CROS DE GmbH, a new wholly-owned subsidiary based in Augsburg, Germany. The company, born from the experience of a German-based CRO, Estimate GmbH, is specialized in providing statistical services to pharmaceuticals and biotechnology industries. Estimate enrich CROS NT with its expertise and a particular excellence concerning the oncology and dermatology-related research. Estimate was found in 1992
More Releases for CRO
Imaging CRO Services Market: Competitive Dynamics & Global Outlook 2020-2025
Global Info Research offers a latest published report on Imaging CRO Services Analysis and Forecast 2020-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Imaging CRO Services Concentrate players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. Click to view the full report TOC, figure
Global CRO Services Market Size, Status and Forecast
This report studies the global CRO Services market size, industry status and forecast, competition landscape and growth opportunity. This research report categorizes the global CRO Services market by companies, region, type and end-use industry. Contract research organization (CRO) provide clinical trial and other research support services for the pharmaceutical, biotechnology, medical device industries and also serve government institutions, foundations and universities. Get sample copy of the report: www.marketdensity.com/contact?ref=Sample&reportid=75298 Table of Contents: Table of Contents Global
Global Contract Research Organization (CRO) Market Developments and Innovations …
Qyresearchreports include new market research report "Global Contract Research Organization (CRO) Market Size,Status and Forecast 2025" to its huge collection of research reports. Contract research organization (CRO) provide clinical trial and other research support services for the pharmaceutical, biotechnology, medical device industries and also serve government institutions, foundations and universities. CROs provide drug development services, regulatory and scientific support, and infrastructure and staffing support to provide their clients with the flexibility to
Global CRO Services Market Size, Status and Forecast 2022
This report studies the global CRO Services market, analyzes and researches the CRO Services development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like Sino Biological Inc. HCL Technologies CTMG, Inc. Powered Research, LLC? Blue Sky BioServices Biomapas Integrated Resources Inc ICON Plc Celsion Labs? Sample of this report is available upon request @ http://www.qyresearchreports.com/sample/sample.php?rep_id=1310184&type=E Market segment by Regions/Countries, this report covers United States EU Japan China India Southeast Asia Market segment by
CRO Services Industry Worldwide Growth and Development
ReportsWeb.com has announced the addition of the “Global CRO Services Market Size, Status and Forecast 2022” The report focuses on global major leading industry players with information such as company profiles, product picture and specification. This report studies the global CRO Services market, analyzes and researches the CRO Services development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in
Partnership factors in sponsor – CRO relationships
Drugs discovered today can realistically cost upwards of 900 million dollars and around 12 years of development to reach a market. CRO’s have been increasingly used by larger pharma to outsource their clinical research, allowing big pharma to shut down in-house R&D, in practice saving money. There have been some issues however with the outsourcing of trials to CROs, including serious relationship break down with negative attitudes, failure to communicate